Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in the USA / NCT06831409
Recruiting Observational

Using CTA Measures to Define Cardiac Risk In NFL Alumni

NCT06831409 · tracked via the Priya Life Science USA tracker
Sponsor
HeartFlow, Inc
Phase
Observational
Started
2024-12-17
Last updated
2025-08-26

Condition(s) studied

Coronary Artery Disease (CAD)Heart DiseaseCoronary Atherosclerosis

Investigational drug(s) / intervention(s)

Coronary computed tomography angiography

Coronary computed tomography angiography: Coronary Computed Tomography Angiography (CCTA) is a non-invasive medical imaging test that uses X-rays to create detailed 3D images of the heart and its blood vessels, specifically the coronary arteries.

Study summary

The GAMEFILM Registry is a post-market, multi-center, data collection study assessing the presence of CAD in NFL alumni.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Retired NFL player Exclusion Criteria: * CCTA not successfully processed for FFRct and AI-Plaque

Primary outcome measure(s)

  • Participants with CAD — 24 hours from the time CCTA was taken
    The proportion of participants with coronary artery disease demonstrated on coronary computed tomography angiography (CCTA).

Trial sites (1)

FacilityCityRegionStatus
Boone Heart Institute Greenwood Village Colorado Recruiting

More HeartFlow, Inc. trials in the USA

REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care Starting soon
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI Recruiting
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management Active, not recruiting
REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease Starting soon

Other trials for the same condition

The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries Recruiting
A Usability Study of a Multi-channel ECG Monitoring Device Recruiting
Analysis of ECGio to Predict Coronary Stenosis Against a Mixed Reference Standard Starting soon
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery. Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06831409 on ClinicalTrials.gov ↗ ← All trials in the USA